Atlas Trials

This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis C

Clinical trial NCT01528735 · COMPLETED

Trial details

NCT number
NCT01528735
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis C, Chronic
Start date
2012-02-01
Primary completion
2013-08-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.